CD274 and large cell neuroendocrine carcinoma: Of 21 large cell neuroendocrine carcinomas, 6 (28.6%) were PD-L1 positive, including 5 (23.8%) with TPS of 1–49% and 1 (4.8%) with TPS of ≥50%.